Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Cancer Research|September 1, 1985
HTLV-III exposure among drug usersH M Ginzburg, S H Weiss, M G MacDonald, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug usersK P Cantor, S H Weiss, J J Goedert, et al.Clinical and Experimental Immunology|August 1, 1987
Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteinsA Ranki, S H Weiss, S L Valle, et al.Annals of Internal Medicine|November 1, 1985
Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndromeW A Blattner, R J Biggar, S H Weiss, et al.Cancer Research|September 1, 1985
Epidemiology of human lymphotrophic retroviruses: an overviewW A Blattner, R J Biggar, S H Weiss, et al.Cell|April 3, 1992
Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9M R Gailani, S J Bale, D J Leffell, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Trends in HIV infection among intravenous drug users in Innsbruck, AustriaR Zangerle, D Fuchs, H Rössler, et al.JAMA|January 11, 1985
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applicationsS H Weiss, J J Goedert, M G Sarngadharan, et al.Journal of Medical Virology|September 1, 1986
Excretion of cytomegalovirus in semen associated with HTLV-III seropositivity in asymptomatic homosexual menC R Rinaldo, L A Kingsley, D W Lyter, et al.JAMA|April 19, 1985
Development and early natural history of HTLV-III antibodies in persons with hemophiliaM E Eyster, J J Goedert, M G Sarngadharan, et al.Pageof 8